Publications Database

Alanazi A. S. (2013)

The role of nutraceuticals in the management of autism.

Saudi Pharmaceutical Journal

21(3), pp. 233-243.

Read Abstract (New Window)

Brkanac Z. , Raskind W. H. , King B. H. (2008)

Pharmacology and genetics of autism: implications for diagnosis and treatment.

Personalized Medicine

5(6), pp. 599-607

Read Abstract (New Window) Read Full (New Window)

Burd L. , Fisher W. W. , Kerbeshian J. (1989)

Pervasive disintegrative disorder: Are Rett syndrome and Hellers dementia infantalis subtypes?

Developmental Medicine and Child Neurology

31(5), pp. 609-616.

Read Abstract (New Window)

Canitano R. (2013)

Novel treatments in autism spectrum disorders: from synaptic dysfunction to experimental therapeutics.

Behavioural Brain Research

251 pp. 125-132.

Read Abstract (New Window)

Carter M. T. , Scherer S. W. (2013)

Autism spectrum disorder in the genetics clinic: a review.

Clinical Genetics

83(5), pp. 399-407.

Read Abstract (New Window)

Glaze D. et al. (1987)

Rett's syndrome: characterization of respiratory patterns and sleep.

Annals of Neurology

21(4), pp. 377-382

Read Abstract (New Window)

Kalra V. , Seth R. , Sapra S. (2005)

Autism: experiences in a tertiary care hospital.

Indian Journal of Pediatrics

72(3), pp. 227-230

Read Abstract (New Window)

Merrick J. , Kandell I. , Morad M. (2004)

Trends in autism.

International Journal of Adolescent Medicine and Health

16(1), pp. 75-78

Read Abstract (New Window)

Miyamoto A. et al. (1999)

Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome.

Brain and Development

21(1), pp. 59-62

Read Abstract (New Window)

Posey D. J. et al. (2001)

A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

11(3), pp. 267-277

Read Abstract (New Window)

Ramaekers V. et al. (2007)

Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits.

Neuropediatrics

38(6), pp 276-281

Read Abstract (New Window)

Rimland B. (2001)

Controlling self-injurious and assaultive behavior in autism.

Autism Research Review International

15(4), p. 3

Rossignol D. A. , Frye R. E. (2011)

Melatonin in autism spectrum disorders: a systematic review and meta-analysis.

Developmental Medicine and Child Neurology

53(9), pp. 783-792

Read Abstract (New Window)

Segawa M. , Nomura Y. (1992)

Polysomnography in the Rett syndrome.

Brain and Development

pp. S46-54.

Read Abstract (New Window)

Sigafoos J. et al. (2009)

Communication intervention in Rett syndrome: A systematic review.

Research in Autism Spectrum Disorders

3(2), pp. 304-318

Read Abstract (New Window)

Sponheim E. (1996)

Changing criteria of autistic disorders: a comparison of the ICD-10 research criteria and DSM-IV with DSM-III-R, CARS, and ABC.

Journal of Autism and Developmental Disorders

26(5), pp. 513-525

Read Abstract (New Window)

Wang H. et al. (2015)

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.

Frontiers in Cellular Neuroscience

Read Abstract (New Window) Read Full (New Window)

Willemsen-Swinkels S. H. , Buitelaar J. K. (2002)

The autistic spectrum: subgroups, boundaries, and treatment.

Psychiatric Clinics of North America

25(4), pp. 811-836

Read Abstract (New Window)

Young D. J. et al. (2008)

The diagnosis of autism in a female: could it be Rett syndrome?

European Journal of Pediatrics

167(6), pp. 661-669

Read Abstract (New Window)